香港股市 已收市

Evolent Health, Inc. (EVH)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
26.94-0.25 (-0.92%)
收市價: 04:00PM EST
26.94 -0.01 (-0.06%)
收市後: 04:01PM EST
全螢幕
交易股價資料並非來自所有市場
前收市價27.19
開市27.23
買盤26.60 x 900
賣出價29.37 x 800
今日波幅26.83 - 27.65
52 週波幅21.36 - 39.78
成交量472,043
平均成交量1,149,669
市值2.726B
Beta 值 (5 年,每月)1.58
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-0.38
業績公佈日2023年2月21日 - 2023年2月27日
遠期股息及收益率無 (無)
除息日
1 年預測目標價42.25
  • Benzinga

    This Analyst Is Bullish On Evolent Health's Recent Deal, Calls 'Highly Strategic Acquisition'

    Thursday after close, Evolent Health Inc (NYSE: EVH) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene Corporation (NYSE: CNC), for $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance. William Blair is positive on the acquisition and believes this is consistent with management's prior commentary that Evolent would consider strategic assets that fit under the specialty care man

  • Benzinga

    Centene Agrees To Divest Magellan Specialty Health To Evolent Health

    Evolent Health Inc (NYSE: EVH) has agreed to acquire NIA (also known as Magellan Specialty Health), the specialty benefit management organization owned by Centene Corporation (NYSE: CNC). The organization focuses on managing cost and quality in radiology, musculoskeletal, physical medicine, and genetics. Deal consideration includes $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance. The upfront consideration will be partly funded by

  • Insider Monkey

    Ray Dalio Stock Portfolio Q3 2022: Top 10 Small-Cap Stocks

    In this article, we discuss the top 10 small-cap stocks from Ray Dalio’s Q3 2022 portfolio. If you want to see more stocks in this selection, check out Ray Dalio Stock Portfolio Q3 2022: Top 5 Small-Cap Stocks. According to Royce Investment Partners, although equity prices declined in the volatile market environment through the first […]